Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3150-3162
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3150
Table 5 Correlation between BMI and anthropometric, clinical and metabolic parameters considered in this study at baseline and at end-treatment
ParameterP valueParameterP value
Steatosis gradeBL0.499TG/HDLBL0.370
6M0.013a6M0.416
Waist circumf. (cm)BL< 0.01aAIPBL0.194
6M< 0.01a6M0.307
Hip-to-waist ratio (-)BL0.231HOMA-IR (mU/L)BL< 0.01a
6M0.020a6M< 0.01a
Tot Chol (mg/dL)BL0.257QUICKIBL< 0.01a
6M< 0.01a6M< 0.01a
HDL (mg/dL)BL0.255PLRBL0.213
6M< 0.01a6M0.645
LDL (mg/dL)BL0.211NLRBL0.066
6M0.7686M0.167
TG (mg/dL)BL0.352FLIBL< 0.01a
6M0.2296M0.137
ASTBL0.244Kotronen index (%)BL0.038a
6M0.0936M< 0.01a
ALTBL0.504VAIBL0.479
6M0.1546M0.373
AST/ALTBL0.195NAFLD fat liver scoreBL< 0.01a
6M0.1146M< 0.01a
GGTBL0.075LAP (male)BL< 0.01a
6M0.1766M< 0.01a
MS (n)BL0.025aLAP (female)BL0.075
6M0.025a6M0.176
Blood gluc. (mg/dL)BL0.182BARDBL< 0.01a
6M0.1426M0.079
Tot-Chol/HDLBL0.218NAFLDBL0.058
6M0.0906M0.167
LDL/HDLBL0.185MedDiet ScoreBL0.049a
6M0.0876MNA